Shares of The Estée Lauder Companies Inc. (NYSE: EL) were down over 2% on Thursday despite the company delivering better-than-expected earnings results for the third quarter of 2025. The beauty giant witnessed a pickup in organic sales trends and is optimistic on returning to sales growth in fiscal year 2026.
Q3 numbers
Estee Lauder’s sales and earnings declined on a year-over-year basis in Q3 2025 but surpassed analysts’ projections. Net sales decreased 10% to $3.55 billion but beat estimates of $3.52 billion. Organic sales were down 9%. GAAP earnings per share fell 52% to $0.44 in the quarter. Adjusted EPS declined 33% to $0.65 but came way ahead of projections of $0.30.
Business performance
During the third quarter, Estee Lauder saw sales decline across all its segments and geographic regions on both a reported and organic basis. The highest declines were in the Skin Care and Hair Care segments, with both decreasing 12% YoY on a reported basis. The Skin Care segment was impacted by softness in the Asia travel retail business and weak sentiment in China.
Organic sales decreased 5% in the Americas, driven by a mid-single-digit decline in North America. The decline in North America was mainly due to ongoing retail softness for some brands and a drop in consumer confidence as well as operational challenges which impacted certain retailers and timing of shipments.
The biggest sales decline of 16% came from the Europe, Middle East & Africa region, mainly due to a double-digit decline in the global travel business, and a mid-single-digit decline in the region’s markets, primarily driven by challenges in the UK. Asia/Pacific sales dipped 1%, driven by double-digit declines in Hong Kong SAR and Korea.
Outlook
Estee Lauder anticipates a stronger double-digit sales decline in its global travel retail business in the fourth quarter of 2025 compared to the third quarter, due to a shift towards more profitable duty-free business models in Korea and China and weak consumer sentiment in China. The company also expects a high-single-digit organic sales decline in Asia/Pacific in fiscal year 2025 due to the weakness in China.
Based on these factors, EL has forecast its net sales for the full year of 2025 to decline 8-9% on both a reported and organic basis. The company expects a GAAP loss of $1.61-1.89 per share for the year. Adjusted EPS is expected to range between $1.30-1.55, representing a 40-50% decrease YoY.
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
DIS Earnings: All you need to know about Walt Disney’s Q4 2025 earnings results
The Walt Disney Company (NYSE: DIS) reported its fourth quarter 2025 earnings results today. Revenues of $22.5 billion were comparable to the year-ago quarter. Net income attributable to The Walt
Cisco (CSCO) reports higher Q1 revenue and earnings; results beat estimates
Network gear maker Cisco Systems Inc. (NASDAQ: CSCO) on Wednesday announced financial results for the first quarter of fiscal 2026, reporting higher revenue and profit. Earnings, on an adjusted basis,
Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO
CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat cancer, with a focus on hematologic malignancies and solid tumors. In an email conversation with